Company Filing History:
Years Active: 2005
Title: Helmut Morack: Innovator in Androgen Receptor Research
Introduction
Helmut Morack is a notable inventor based in Blankenfelde, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target androgen receptors. His work is crucial for advancing treatments for conditions such as prostate cancer.
Latest Patents
Morack holds a patent for "Piperazine derivatives that destabilize androgen receptors." This invention relates to new piperazine derivatives of general formula I, where V, W, n, R, R', i, j, Y, and Z are defined in the patent description. The compounds are characterized by a diazacycloalkane substituent and exhibit a unique action that destabilizes the androgen receptor. This property makes them valuable for therapeutic applications, particularly in treating prostate cancer. He has 1 patent to his name.
Career Highlights
Helmut Morack has been associated with Schering Aktiengesellschaft, a prominent pharmaceutical company. His work there has focused on innovative solutions in drug development, particularly in the area of hormone-related therapies. His research has contributed to the understanding of androgen receptor mechanisms and their implications in cancer treatment.
Collaborations
Throughout his career, Morack has collaborated with esteemed colleagues, including Arwed Cleve and Christoph Huwe. These partnerships have fostered a collaborative environment that enhances research outcomes and drives innovation in the pharmaceutical field.
Conclusion
Helmut Morack's contributions to the field of medicinal chemistry, particularly through his patent on piperazine derivatives, highlight his role as an innovator in androgen receptor research. His work continues to influence the development of new therapeutic strategies for prostate cancer.